chloramphenicol topical treatment and agranulocytosis
- the evidence of a causal relationship between the use of topical chloramphenicol and agranulocytosis is not compelling (1,2)
- (1) Doon M, Walsh JB (1995). Use of chloramphenicol as a topical eye medication, time to cry a halt?. BMJ, 310, 12178.
- (2) Walker S et al (1998). Lack of evidence of toxicity following topical chloramphenicol use. Eye, 12, 8759.
Last reviewed 01/2022